Warning: First Human Trial Using CRISPR Gene-Editing Technology
Warning: First Human Trial Using CRISPR Gene-Editing Technology
The first human trial using CRISPR cas 9 gene-editing technology is underway.
Dr Sandy Macrae of Sangamo Therapeutics, the California company testing this for two metabolic diseases and hemophilia described the technique as “invisible mending”.”It becomes part of your DNA and is there for the rest of your life,” Dr Macrae told AP.
In another test scientists find that social behavior in ants was a bi-product of using the gene-editing technology. The experiment caused chaos in the ant colony due to the anti-social side effect.
We’ve been warned of what this type of genome editing can cause. The author of Homo Deus, Yuval Noah Harari, has spoken on the subject.
“In the coming century humankind may have the ability to, first of all, replace natural selection with intelligent design as the fundamental principle of the evolution of life. Not the intelligent design of some god above the clouds, but our intelligent design will be the main driving force of the evolution of life.” -Yuval Noah Harari
For more of his speech:
God bless and carry on.
- CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
- CRISPR 2.0: Base Editing in the Groove – Genetic Engineering & Biotechnology News
- The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
- The Code Breaker and Crispr People — the ethics of editing humanity – Financial Times
- ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
- The Dark Side of CRISPR – Scientific American
- ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
- Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
- DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
- CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
- Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
- New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
- After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
Leave a Reply
You must be logged in to post a comment.